Pharmaceutical Sciences Master  |
 Kernfächer I |
| Nummer | Titel | Typ | ECTS | Umfang | Dozierende |
|---|
| 535-0030-00L | Pharmaceutical Immunology II & Therapeutic Proteins  Als Voraussetzung muss entweder die 535-0830-00L Pharmaceutical Immunology I oder 551-0317-00L Immunologie I besucht worden sein. | O | 3 KP | 3G | C. Halin Winter,
D. Neri |
| 535-0041-00L | Pharmacology and Toxicology III | O | 2 KP | 2G | U. Quitterer,
M. Arand,
Y. Yamauchi |
| 535-0050-00L | Pharmacoepidemiology and Drug Safety | O | 3 KP | 2G | A. Burden,
S. Russmann |
| 535-0546-00L | Patents | O | 1 KP | 1V | C. Ebner,
P. Pliska |
| 511-0000-00L | Drug Discovery and Development | O | 2 KP | 1G + 2S | J. Hall,
U. Thibaut,
K.‑H. Altmann,
M. Arand,
J. Scheuermann,
R. Schibli,
H. U. Zeilhofer |
| 511-0007-00L | Scientific Writing and Presenting | O | 2 KP | 2G | J. A. Hiss,
A. Burden,
J. Dolenc,
J.‑C. Leroux,
O. Renn,
C. Steuer |
|
| Wahlfächer I |
| Nummer | Titel | Typ | ECTS | Umfang | Dozierende |
|---|
| 535-0011-00L | Drug Seminar | W | 5 KP | 9S | J.‑C. Leroux,
A. Burden,
K. Eyer,
C. Halin Winter,
J. Hall,
S.‑D. Krämer,
C. Müller,
V. I. Otto,
U. Quitterer,
J. Scheuermann,
R. Schibli,
K. Silina,
C. Steuer |
| 511-1001-00L | Biopharmacy (Crash Course) Obligatory course if assigned by the Admission committee. | E- | 2 KP | 1S | S.‑D. Krämer |
| 511-1002-00L | Pharmaceutical Analytics and Pharmacopeia (Crash Course) Obligatory course if assigned by the Admission committee. | E- | 2 KP | 1S | C. Steuer |
| 511-1003-00L | Gene Technology (Crash Course) Obligatory course if assigned by the Admission committee. | E- | 1 KP | 1S | J. Scheuermann |
| 535-0423-00L | Drug Delivery and Drug Targeting | W | 2 KP | 1.5V | J.‑C. Leroux |
| 535-0250-00L | Biotransformation of Drugs and Xenobiotics | W | 1 KP | 1V | S.‑D. Krämer |
| 535-0015-00L | Geschichte der Pharmazie | W | 1 KP | 1V | S. Ruppen |
| 535-0344-00L | Von Ethnopharmazie zu molekularer Pharmakognosie | W | 1 KP | 1V | B. Frei Haller,
A. Lardos |
| 535-0310-00L | Glycobiology in Drug Development | W | 1 KP | 1V | V. I. Otto |
| 535-0300-00L | Molecular Mechanisms of Drug Actions and Targets | W | 2 KP | 1V | J. Scheuermann |
| 535-0021-00L | Vitamine in der Vorsorge und Therapie | W | 1 KP | 1V | C. Müller |
| 535-0360-00L | Rationale Phytotherapie an ausgewählten Beispielen | W | 1 KP | 1V | K. Berger Büter |
| 535-0137-00L | Clinical Chemistry II | W | 1 KP | 1V | M. Hersberger |
| 535-0022-00L | Computer-Assisted Drug Design | W | 1 KP | 1V | S. Riniker,
G. Landrum |
Seite
1
von
2
Alle